22nd Jan 2019 13:35
LONDON (Alliance News) - Shield Therapeutics PLC said Tuesday that it has promoted board member James Karis to be non-executive chair with immediate effect.
Karis has served on Shield's board for almost three years as a member of the audit and nominations committees and as chair of the remuneration committee. Most recently, Karis was chief executive of privately held MAPI Group until its sale to ICON PLC in 2018.
Shares in the commercial-stage pharmaceutical company were trading 0.4% higher at 35.64 pence each on Tuesday afternoon.
Related Shares:
Shield Thera